Thyroglobulin level as a predictive factor of tumoral recurrence in differentiated thyroid cancer
- PMID: 2005446
Thyroglobulin level as a predictive factor of tumoral recurrence in differentiated thyroid cancer
Abstract
Ninety-eight patients with differentiated thyroid carcinoma were studied. Actuarial methods were used to investigate the 10-yr probability of survival (pS) and disease-free survival (pDFS). Our results show that the pDFS is a function of: (1) clinicopathologic stage: Stages I-II, pDFS = 90.9% +/- 5.0% versus Stages III-IV, pDFS = 55.9% +/- 17.8% (p less than 0.005); (2) age: Age less than 45 yr, pDFS = 87.2% +/- 10.0% versus age greater than or equal to 45 yr, pDFS = 66.6% +/- 12.0% (p less than 0.002); and (3) plasma thyroglobulin (Tg) levels: Tg less than or equal to 23 ng/ml, pDFS = 100% versus Tg greater than 23 ng/ml, pDFS = 68.3% +/- 10.6% (p less than 0.005). Using the multivariate analysis of proportional risk, the regression coefficients obtained (Stage: beta = 0.7615; Age: beta = 1.6398, and Tg: beta = 1.7607) allowed us to establish two different groups of risk of relapse on the basis of a prognostic index.
Similar articles
-
Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.Ann Surg Oncol. 2009 Feb;16(2):473-80. doi: 10.1245/s10434-008-0211-9. Epub 2008 Nov 18. Ann Surg Oncol. 2009. PMID: 19015922
-
Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.Clin Endocrinol (Oxf). 2007 Oct;67(4):547-51. doi: 10.1111/j.1365-2265.2007.02922.x. Epub 2007 Jun 11. Clin Endocrinol (Oxf). 2007. PMID: 17561976
-
Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):485-9. doi: 10.1055/s-2006-951778. Exp Clin Endocrinol Diabetes. 2006. PMID: 17115345
-
Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.J Surg Oncol. 2002 May;80(1):45-51. doi: 10.1002/jso.10089. J Surg Oncol. 2002. PMID: 11967907
-
Surgical treatment of papillary and follicular thyroid carcinoma.Int Surg. 1996 Jan-Mar;81(1):61-6. Int Surg. 1996. PMID: 8803709
Cited by
-
Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma.Nucl Med Mol Imaging. 2014 Dec;48(4):255-61. doi: 10.1007/s13139-014-0282-4. Epub 2014 Jun 28. Nucl Med Mol Imaging. 2014. PMID: 26396629 Free PMC article.
-
Postoperative stimulated thyroglobulin level and recurrence risk stratification in differentiated thyroid cancer.Chin Med J (Engl). 2015 Apr 20;128(8):1058-64. doi: 10.4103/0366-6999.155086. Chin Med J (Engl). 2015. PMID: 25881600 Free PMC article.
-
Clinical implication of cancer adhesion in papillary thyroid carcinoma: clinicopathologic characteristics and prognosis analyzed with degree of extrathyroidal extension.World J Surg. 2013 Jul;37(7):1606-13. doi: 10.1007/s00268-013-2034-5. World J Surg. 2013. PMID: 23584460
-
Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis.BMC Cancer. 2010 May 20;10:217. doi: 10.1186/1471-2407-10-217. BMC Cancer. 2010. PMID: 20487521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous